Form 4 Filing for Axogen, Inc. - Thomas Paul

This SEC filing (Form 4) details a transaction by Thomas Paul, a director at Axogen, Inc. On June 19, 2026, Mr. Paul was granted 18,867 Restricted Stock Units (RSUs) which vested on the same day. These RSUs represent a contingent right to receive one share of Axogen, Inc. common stock each. The grant, valued at $200,000 as of the grant date, is an annual equity award for his service as a Director. The transaction code "M" indicates a grant, and the "A" for acquired disposed code signifies an acquisition. The filing also notes that post-transaction, Mr. Paul holds 32,395 shares of Common Stock directly. The zero transaction price per share reflects that this was an equity grant rather than a purchase.